(Q36639818)

English

Vaccination with irradiated autologous melanoma cells engineered to secrete human granulocyte-macrophage colony-stimulating factor generates potent antitumor immunity in patients with metastatic melanoma

scientific article published on October 1998

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Vaccination with irradiated autologous melanoma cells engineered to secrete human granulocyte-macrophage colony-stimulating factor generates potent antitumor immunity in patients with metastatic melanoma (English)

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

1 reference

based on heuristic

inferred from title

metastatic melanoma

1 reference

based on heuristic

inferred from title

Colony stimulating factor 2

1 reference

based on heuristic

inferred from title

author name string

R Soiffer

1

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

T Lynch

2

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

M Mihm

3

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

K Jung

4

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

C Rhuda

5

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

J C Schmollinger

6

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

F S Hodi

7

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

L Liebster

8

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

P Lam

9

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

S Mentzer

10

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

S Singer

11

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

K K Tanabe

12

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

A B Cosimi

13

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

R Duda

14

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

A Sober

15

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

A Bhan

16

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

J Daley

17

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

D Neuberg

18

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

G Parry

19

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

J Rokovich

20

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

L Richards

21

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

J Drayer

22

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

A Berns

23

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

S Clift

24

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

L K Cohen

25

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

R C Mulligan

26

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

G Dranoff

27

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

language of work or name

0 references

publication date

1 October 1998

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Proceedings of the National Academy of Sciences of the United States of America

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

95

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

22

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

13141-13146

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Bioactivity of autologous irradiated renal cell carcinoma vaccines generated by ex vivo granulocyte-macrophage colony-stimulating factor gene transfer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=23738

30 September 2017

Clonal expansion of T lymphocytes in human melanoma metastases after treatment with a hapten-modified autologous tumor vaccine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=23738

30 September 2017

Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=23738

30 September 2017

Analysis of T cell receptor variability in tumor-infiltrating lymphocytes from a human regressive melanoma. Evidence for in situ T cell clonal expansion

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=23738

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=23738

30 September 2017

Direct evidence to support the immunosurveillance concept in a human regressive melanoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=23738

30 September 2017

Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=23738

30 September 2017

Activation markers on T cells infiltrating melanoma metastases after therapy with dinitrophenyl-conjugated vaccine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=23738

30 September 2017

Gene transfer as cancer therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=23738

30 September 2017

Induction of antigen-specific cytolytic T cells in situ in human melanoma by immunization with synthetic peptide-pulsed autologous antigen presenting cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=23738

30 September 2017

The histogenesis and biologic behavior of primary human malignant melanomas of the skin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=23738

30 September 2017

The eosinophilic leukocyte: structure and function

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=23738

30 September 2017

https://api.crossref.org/works/10.1073%2FPNAS.95.22.13141

21 January 2018

Stage II malignant melanoma: presentation of a prognostic model and an assessment of specific active immunotherapy in 1,273 patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=23738

30 September 2017

Model predicting survival in stage I melanoma based on tumor progression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=23738

30 September 2017

Cytokines: coordinators of immune and inflammatory responses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=23738

30 September 2017

Long-term spontaneous regression of malignant melanoma with visceral metastasesReport of a case with immunologic profile

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=23738

30 September 2017

A case report: immune responses and clinical course of the first human use of granulocyte/macrophage-colony-stimulating-factor-transduced autologous melanoma cells for immunotherapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=23738

28 June 2018

Polyvalent melanoma cell vaccine induces delayed-type hypersensitivity and in vitro cellular immune response.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=23738

28 June 2018

Active-specific immunotherapy for melanoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=23738

28 June 2018

Immunization with haptenized, autologous tumor cells induces inflammation of human melanoma metastases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=23738

28 June 2018

A phase I study of vaccination with autologous, irradiated melanoma cells engineered to secrete human granulocyte-macrophage colony stimulating factor.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=23738

20 September 2018

Prolongation of survival in metastatic melanoma after active specific immunotherapy with a new polyvalent melanoma vaccine.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=23738

20 September 2018

Evidence that treatment with vaccinia melanoma cell lysates (VMCL) may improve survival of patients with stage II melanoma. Treatment of stage II melanoma with viral lysates

1 reference

https://pubmed.ncbi.nlm.nih.gov/9789055

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antibody to interleukin-5 inhibits helminth-induced eosinophilia in mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/9789055

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Induction of tumor-infiltrating lymphocytes in human malignant melanoma metastases by immunization to melanoma antigen vaccine

1 reference

https://pubmed.ncbi.nlm.nih.gov/9789055

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Autologous melanoma vaccine induces inflammatory responses in melanoma metastases: relevance to immunologic regression and immunotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/9789055

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improved survival in stage III melanoma patients with GM2 antibodies: a randomized trial of adjuvant vaccination with GM2 ganglioside

1 reference

https://pubmed.ncbi.nlm.nih.gov/9789055

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of cytokine mRNA in human melanoma tissues

1 reference

https://pubmed.ncbi.nlm.nih.gov/9789055

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor regression responses in melanoma patients treated with a peptide encoded by gene MAGE-3

1 reference

https://pubmed.ncbi.nlm.nih.gov/9789055

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor infiltrating lymphocytes in lymph node melanoma metastases: a histopathologic prognostic indicator and an expression of local immune response

1 reference

https://pubmed.ncbi.nlm.nih.gov/9789055

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Granulocyte-macrophage-colony-stimulating factor enhances immune responses to melanoma-associated peptides in vivo

1 reference

https://pubmed.ncbi.nlm.nih.gov/9789055

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Autologous hapten-modified melanoma vaccine as postsurgical adjuvant treatment after resection of nodal metastases

1 reference

https://pubmed.ncbi.nlm.nih.gov/9789055

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1073/PNAS.95.22.13141

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

1998PNAS...9513141S

0 references

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36639818&oldid=2148660773"